ANIXA BIOSCIENCES, INC. Earnings Per Share (Basic)
ANIXA BIOSCIENCES, INC. (ANIX) reported Earnings Per Share (Basic) of -$0.08 per share for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2026-07-31 was -$0.08.
- ANIXA BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2026-04-30 was -$0.07.
- ANIXA BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2026-01-31 was -$0.08.
- ANIXA BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2025-07-31 was -$0.07.
- ANIXA BIOSCIENCES, INC. earnings per share, basic for fiscal 2025 was -$0.34.
- ANIXA BIOSCIENCES, INC. earnings per share, basic for fiscal 2024 was -$0.39.
- ANIXA BIOSCIENCES, INC. earnings per share, basic for fiscal 2023 was -$0.32, a 171.11% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. earnings per share, basic for fiscal 2022 was $0.45.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | -$0.08 10-Q · filed 2026-09-09 | -$0.23 10-Q · filed 2026-09-09 | |||||
| 2026-04-30 | -$0.07 10-Q · filed 2026-06-10 | -$0.15 10-Q · filed 2026-06-10 | |||||
| 2026-01-31 | -$0.08 10-Q · filed 2026-03-09 | ||||||
| 2025-10-31 | -$0.34 10-K · filed 2026-01-12 | ||||||
| 2025-07-31 | -$0.07 10-Q · filed 2026-09-09 | -$0.25 10-Q · filed 2026-09-09 | |||||
| 2025-04-30 | -$0.09 10-Q · filed 2026-06-10 | -$0.19 10-Q · filed 2026-06-10 | |||||
| 2025-01-31 | -$0.10 10-Q · filed 2026-03-09 | ||||||
| 2024-10-31 | -$0.39 10-K · filed 2026-01-12 | ||||||
| 2024-07-31 | -$0.10 10-Q · filed 2025-09-10 | -$0.30 10-Q · filed 2025-09-10 | |||||
| 2024-04-30 | -$0.10 10-Q · filed 2025-05-28 | -$0.20 10-Q · filed 2025-05-28 | |||||
| 2024-01-31 | -$0.10 10-Q · filed 2025-03-11 | $0.10 10-Q · filed 2024-03-12 | |||||
| 2023-10-31 | -$0.32 10-K · filed 2025-01-10 | $0.32 10-K · filed 2024-01-16 | |||||
| 2023-07-31 | -$0.08 10-Q · filed 2024-09-06 | -$0.23 10-Q · filed 2024-09-06 | |||||
| 2023-04-30 | -$0.07 10-Q · filed 2024-06-04 | -$0.15 10-Q · filed 2024-06-04 | |||||
| 2023-01-31 | $0.08 10-Q · filed 2024-03-12 | -$0.08 10-Q · filed 2023-03-17 | |||||
| 2022-10-31 | $0.45 10-K · filed 2024-01-16 | -$0.45 10-K · filed 2023-01-04 | |||||
| 2022-07-31 | -$0.09 10-Q · filed 2023-09-06 | -$0.33 10-Q · filed 2023-09-06 | |||||
| 2022-04-30 | -$0.12 10-Q · filed 2023-06-14 | -$0.24 10-Q · filed 2023-06-14 | |||||
| 2022-01-31 | -$0.13 10-Q · filed 2023-03-17 | ||||||
| 2021-10-31 | -$0.45 10-K · filed 2023-01-04 | ||||||
| 2021-07-31 | -$0.14 10-Q · filed 2022-09-09 | -$0.32 10-Q · filed 2022-09-09 | |||||
| 2021-04-30 | -$0.08 10-Q · filed 2022-06-10 | -$0.17 10-Q · filed 2022-06-10 | |||||
| 2018-04-30 | -$0.08 10-Q · filed 2018-06-11 | ||||||
| 2017-04-30 | $0.02 10-Q · filed 2018-06-11 | ||||||
| 2016-04-30 | -$0.15 10-Q · filed 2017-05-26 | -$0.33 10-Q · filed 2016-05-20 | |||||
| 2016-01-31 | -$0.18 10-Q · filed 2016-02-19 | ||||||
| 2015-07-31 | -$0.18 10-Q · filed 2015-08-18 | ||||||
| 2015-04-30 | $0.17 10-Q · filed 2016-05-20 | $0.01 10-Q · filed 2015-05-22 | |||||
| 2015-01-31 | $0.43 10-Q · filed 2016-02-19 | $0.02 10-Q · filed 2015-03-09 | |||||
| 2014-07-31 | $0.05 10-Q · filed 2015-08-18 | ||||||
| 2014-04-30 | -$0.03 10-Q · filed 2015-05-22 | ||||||
| 2014-01-31 | -$0.02 10-Q · filed 2015-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |